EUCTR2007-002664-10-IT进行中（未招募）不适用
A Randomised Comparison Between 150 mg/die Clopidogrel Maintenance Dose Versus 75 mg/die in Patients with ST Segment Elevation Acute Myocardial Infarction: Effects on Platelet Aggregation and Inflammatory Markers - ND
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点目标入组 40 人开始时间: 2007年6月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with ST segment elevation acute myocardial infarction treated with primary PCI within 12 hours of symptoms onset. Age>18 years No complications during the procedure Informed consent
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Shock High risk of bleeding Severe comorbidities with life expectancy < 1 year Pregnant women
研究者
相似试验
已完成
2 期
Comparing the effect of Loading Doses of Clopidogrel and Prasugrel on the incidence of myocardial injury in the Candidates for Elective Percutaneous Coronary InterventioSubsequent myocardial infarction.For morbidity coding, this category should be assigned for infarction of any myocardial site, occurring within 4 weeks (28 days) from onset of a previous infarctionIRCT201408069768N3Tehran University of Medical Sciences90
尚未招募
1 期
Bioequivalence of ClopidogrelHealthy volunteersHealthy VolunteersRPCEC00000257Center for Pharmaceutical Research and Development, Havana, Cuba.24
进行中（未招募）
不适用
A randomized comparison of CLOpidogrel monotherapy versus extended dual-antiplatelet therapy beyond 12 months after implantation of drug-eluting StEnts in high-risk lesions or patients; A-CLOSE trialKCT0003911Yonsei University Health System, Severance Hospital3,200
进行中（未招募）
不适用
A double blind randomized study of Clopidogrel 75 mg/d versus placebo on a background of ASA 75-100 mg/d, in peripheral disease (PAD) patient receiving a unilateral below knee by-pass graft. - CASPAR 2004MedDRA version: 7.0Level: 1Classification code 10062585EUCTR2004-000822-58-SESanofi-Synthelabo Groupe1,460
进行中（未招募）
1 期
A double blind randomized study of Clopidogrel 75 mg/d versus placebo on a background of ASA 75-100 mg/d, in peripheral arterial disease (PAD) patients receiving a unilateral below knee by-pass graft - CASPAR 2004Peripheral arterial diseaseMedDRA version: 7.0Level: 1Classification code 10062585EUCTR2004-000822-58-FIsanofi-synthelabo groupe1,460